ACPE UAN #: 0233-0000-17-043-H01-P
Release Date: August 23, 2017
Expiration Date: August 23, 2019
Activity Type: Knowledge-based
Credit Hours: 1.0 contact hours (0.1 CEU)
Activity Fee: There is no fee to participate in this home study activity.
This home study activity has been designed to meet the educational needs of pharmacists in managed care settings.
Multiple sclerosis (MS) affects approximately 400,000 individuals in the United States and 2.5 million people worldwide. It is a progressive and debilitating disease that is characterized by periods of remission and relapse. Available medications can extend periods between disease flares but cannot reverse the disease process. Treatment of MS must be individualized, but often involves the use of specialty medications that are associated with considerable costs. Common sequelae associated with MS also contribute substantially to the disease burden and costs of caring for affected patients. Adherence to medications is suboptimal due to issues including perceived lack of efficacy and adverse events. Programs designed to support adherence can help patients develop realistic expectations, manage adverse events, improve patient quality of life, and reduce overall costs. In this webinar, experts will discuss current and emerging treatment options for MS, and explore how value-based reimbursement models are increasingly being used by managed care organizations to tailor treatment interventions to individual patients and improve patient satisfaction with therapy.
At the completion of his activity, participants should be able to:
- Summarize current pharmacologic management strategies for multiple sclerosis (MS).
- Identify MS medications in the pipeline and discuss how they may impact the management of MS.
- Discuss current and future payer management strategies and methods for optimizing adherence and medication management for patients with MS.
- Describe options for health plans to implement value-based reimbursement models to manage costs associated with MS.
Schedule of Educational Activity
- Current and Emerging Pharmacologic Treatment Options for Multiple Sclerosis - Gary M. Owens, MD
Management Strategies for Patients with Multiple Sclerosis - Shilpa Klocke, PharmD, BCPS
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live webinar activity on August 23, 2017. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for continuing education online learning activities.
As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
Statement of Commercial Support
This educational activity is supported by an unrestricted education grant from Mylan.
Puneet Singh, PharmD
Education Program Manager
Academy of Managed Care Pharmacy
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-17-043-H01-P||1 Contact Hour||August 23, 2017 - August 23, 2019|